Shimazaki J, Fuse H, Zama S
Gan No Rinsho. 1985 Jul;31(9 Suppl):1195-201.
Response rate of prostatic cancer to endocrine therapy is approximately 80%, but more than half of responders show relapse by five years. Factors influencing prognosis are histological grade, stage, effect of elevated acid phosphatase, and androphilic protein observed histochemically. Relapse may be attributable to progression and clonal selection.
前列腺癌对内分泌治疗的缓解率约为80%，但超过半数的缓解者在五年内会出现复发。影响预后的因素有组织学分级、分期、酸性磷酸酶升高的影响以及组织化学观察到的亲雄激素蛋白。复发可能归因于疾病进展和克隆选择。
